2019
DOI: 10.1007/s11426-018-9404-9
|View full text |Cite
|
Sign up to set email alerts
|

Celastrol as a tool for the study of the biological events of metabolic diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 11 publications
(7 citation statements)
references
References 71 publications
0
7
0
Order By: Relevance
“…The anti-cancer properties of celastrol, one of the most studied methylene quinones, have been attributed to apoptosis and autophagy induction, cell cycle arrest, and anti-metastatic and anti-angiogenic action [ 9 , 10 ]. Other works have evidenced the ability of celastrol in combating metabolic disorders such as obesity and type 2 diabetes [ 11 ]. Treatment with celastrol suppresses food intake, blocks reduction in energy consumption, and mediates weight loss by acting as a leptin sensitizer in mouse models [ 12 , 13 ].…”
Section: Introductionmentioning
confidence: 99%
“…The anti-cancer properties of celastrol, one of the most studied methylene quinones, have been attributed to apoptosis and autophagy induction, cell cycle arrest, and anti-metastatic and anti-angiogenic action [ 9 , 10 ]. Other works have evidenced the ability of celastrol in combating metabolic disorders such as obesity and type 2 diabetes [ 11 ]. Treatment with celastrol suppresses food intake, blocks reduction in energy consumption, and mediates weight loss by acting as a leptin sensitizer in mouse models [ 12 , 13 ].…”
Section: Introductionmentioning
confidence: 99%
“…33 Leptin, secreted mainly from adipocytes, communicates the satiety signal to the hypothalamus and regulates energy homeostasis. 34 Thus, loss of hypothalamic leptin signaling is usually sufficient to cause obesity. 34 In the past decade, the natural product celastrol was found to suppress food intake and substantially reduce body weight as a potent leptin sensitizer in animal models.…”
Section: Discussionmentioning
confidence: 99%
“…According to Schiavone et al, there are several clinical conditions such as Crohn’s disease, psoriasis, rheumatoid arthritis, diabetes, kidney disease, and transplantation with promising results of celastrol administration [ 115 ]. In vitro and in vivo animal studies suggested that celastrol has antidiabetic effects and improves diabetic nephropathy and whole-body insulin resistance, due to the inhibition of NF-κB in the hypothalamus [ 133 ]. In mice, celastrol showed obesity-controlling effects by inhibiting negative regulators of leptin [ 134 ], and reduced obesity-induced OS by increasing antioxidant enzymes and inhibiting NADH oxidase and ROS [ 135 ].…”
Section: Celastrolmentioning
confidence: 99%